Puhua Heshun (01358.HK) issued a profit warning, expecting a mid-term profit attributable to shareholders of 13 million to 20 million, a year-on-year decrease of 80% to 70%.

Zhihong Finance APP reported that PwC (01358.HK) announced that the Group expects to (i) achieve a net profit ranging from RMB 32 million to RMB 49 million for the six months ending June 30, 2026, a decrease of 63% to 43% compared to approximately RMB 86.6 million for the six months ending June 30, 2025; and (ii) achieve profit attributable to the owners of the Company ranging from RMB 13 million to RMB 20 million for the six months ending June 30, 2026, a decrease of 80% to 70% compared to approximately RMB 66 million for the six months ending June 30, 2025. The decrease is primarily due to the infusion business segment, where the comprehensive implementation of centralized procurement policies has significantly affected sales in regions such as Beijing, leading to a substantial drop in product prices, which in turn resulted in a significant decline in sales revenue and gross profit margin.